Sustained Efficacy Responses and a Consistent Safety Profile with Rituximab Repeat Treatment Over 5 Years in Patients with Rheumatoid Arthritis and an Inadequate Response to Tumour Necrosis Factor Inhibitors

被引：0
|
作者：
Keystone, Edward [1 ]
Cohen, Stanley B. [2 ]
Emery, Paul [3 ]
Kremer, Joel M. [4 ]
Dougados, Maxime R. [5 ]
Loveless, James E. [6 ]
Chung, Carol [7 ]
Wong, Pamela [7 ]
Lehane, Patrica B. [8 ]
Tyrrell, Helen [8 ]
机构：
[1] Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada
[2] Metroplex Clin Res Ctr, Dallas, TX USA
[3] Univ Leeds, Leeds, W Yorkshire, England
[4] Albany Med Coll, Albany, NY 12208 USA
[5] Univ Paris 05, Paris, France
[6] St Lukes Rheumatol, Boise, ID USA
[7] Genentech Inc, San Francisco, CA 94080 USA
[8] Roche Prod Ltd, Welwyn Garden City AL7 3AY, Herts, England
来源：
ARTHRITIS AND RHEUMATISM | 2012年 / 64卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1280
引用
收藏
页码：S548 / S548
页数：1
相关论文
共 50 条
  • [1] SUSTAINED INHIBITION OF STRUCTURAL DAMAGE IN PATIENTS WITH RHEUMATOID ARTHRITIS AND AN INADEQUATE RESPONSE TO TUMOUR NECROSIS FACTOR INHIBITORS PRIOR TO RITUXIMAB TREATMENT: 5-YEAR DATA FROM THE REFLEX STUDY
    Keystone, E.
    Cohen, S. B.
    Emery, P.
    Kremer, J. M.
    Dougados, M.
    Loveless, J. E.
    Chung, C.
    Wong, P.
    Lehane, P. B.
    Tyrrell, H.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 374 - 374
  • [2] The efficacy of biologic agents in patients with rheumatoid arthritis and an inadequate response to tumour necrosis factor inhibitors: a systematic review
    Moots, Robert J.
    Naisbett-Groet, Barbara
    RHEUMATOLOGY, 2012, 51 (12) : 2252 - 2261
  • [3] Longterm Safety and Efficacy of Abatacept Through 5 Years of Treatment in Patients with Rheumatoid Arthritis and an Inadequate Response to Tumor Necrosis Factor Inhibitor Therapy
    Genovese, Mark C.
    Schiff, Michael
    Luggen, Michael
    Le Bars, Manuela
    Aranda, Richard
    Elegbe, Ayanbola
    Dougados, Maxime
    JOURNAL OF RHEUMATOLOGY, 2012, 39 (08) : 1546 - 1554
  • [4] Repeated treatment courses of rituximab in rheumatoid arthritis: Sustained efficacy in patients with an inadequate response to one or more TNF inhibitors
    Keystone, E.
    Fleischmann, R. M.
    Emery, P.
    Chubick, A.
    Dougadoss, M.
    Baldassare, A. R.
    Bathon, J. M.
    Hessey, E.
    Hagerty, D.
    Coopers, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 432 - 432
  • [5] Long-term efficacy and safety of a repeat treatment course of rituximab in rheumatoid arthritis patients with an inadequate response to one or more TNF inhibitors
    Keystone, E.
    Fleischmann, R.
    Emery, P.
    Chubick, A.
    Dougados, M.
    Baldassares, A. R.
    Bathon, J. M.
    Hessey, E.
    Totoritis, M.
    Cooper, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 323 - 324
  • [6] Long-term efficacy and safety of a repeat treatment course of rituximab in rheumatoid arthritis patients with an inadequate response to one or more TNF inhibitors
    Keystone, E.
    Pope, J. E.
    Fleischmann, R.
    Emery, P.
    Chubick, A.
    Dougados, M.
    Baldassare, A. R.
    Bathon, J. M.
    Hessey, E.
    Totoritis, M.
    Cooper, S.
    JOURNAL OF RHEUMATOLOGY, 2007, 34 (07) : 1617 - 1618
  • [7] EFFICACY AND SAFETY OF TUMOUR NECROSIS FACTOR ALPHA INHIBITORS IN RHEUMATOID ARTHRITIS
    Baraza Cristina, Gomez
    Francisco Javier, Manero Ruiz
    Espasol Angela, Pecondon
    Mendoza Mercedes, Arenere
    Orbis Iciar, Casiamares
    Maria Jose, Rabanaque Hernandez
    ATENCION FARMACEUTICA, 2013, 15 (03): : 150 - 157
  • [8] Sustained Clinical Efficacy after Multiple Courses of Rituximab in Rheumatoid Arthritis Patients with Inadequate Response to Tumor Necrosis Factor Inhibitors: 3-Year Data from Repeat.
    Codreanu, Catalin
    Ionescu, Ruxandra
    Ancuta, Ioan
    Mogosan, Corina
    Rednic, Simona
    Ciurea, Paulina
    Suta, Maria
    Parvu, Magda
    Balanescu, Andra
    Bojinca, Mihai
    Nemes, Dan
    Ancuta, Codrina
    Rezus, Elena
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S672 - S672
  • [9] SAFETY AND EFFICACY OF OCRELIZUMAB IN RHEUMATOID ARTHRITIS PATIENTS WITH AN INADEQUATE RESPONSE TO METHOTREXATE OR TUMOUR NECROSIS FACTOR INHIBITORS: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Ahmed, Hussien
    Abushouk, Abdelrahman Ibrahim
    Ismail, Ammar
    Elmaraezy, Ahmed
    Badr, Ahmed Said
    Gadelkarim, Mohamed
    Elnenny, Mohammed
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : A8 - A8
  • [10] Long-term efficacy and safety of a repeat treatment course of rituximab in rheumatoid arthritis patients with an inadequate response to one or more TNF inhibitors.
    Keystone, E.
    Fleischmann, R. M.
    Emery, P.
    Chubick, A.
    Dougados, M.
    Baldassare, A. R.
    Bathon, J. M.
    Hessey, E.
    Totoritis, M.
    Cooper, S.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S328 - S328
12345